Zyomyx and Speciality search for disease profiles:
This article was originally published in Clinica
Executive Summary
Zyomyx and Speciality Laboratories are to collaborate on a programme to discover new patterns of disease markers that have greater clinical use than traditional single-analyte tests. Zyomyx' Protein Profiling Biochip platform, which can measure dozens of analytes in a drop of fluid, will be combined with Speciality's large archive of biological samples and diagnostic results to help discover the markers, says Zyomyx, of Hayward, California. Speciality will obtain exclusive rights to provide in-house testing services based on any disease marker profiles resulting for the collaboration, and will pay Zyomyx royalties for these testing services. Zyomyx retains the rights to other fields of use.